Posts Tagged alzheimers medication

Politicians Not Doing Enough To Improve Care For Older People, UK

Sixty per cent of people think politicians are not doing enough to improve care for older people according to a survey by Age Concern and Help the Aged. The poll also found that eight out of ten adults believe care reform is among the most important issues in the forthcoming election...

A Purpose-Filled Life May Stave Off Alzheimer’s

Having a purpose in life may help ward off Alzheimer's disease, a new study suggests.

Politicians not doing enough to improve care for older people

Sixty per cent of people think politicians are not doing enough to improve care for older people according to a survey by Age Concern and Help the Aged. (Source: Alzheimers Society)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Stress, the Brain, Aging and Alzheimer’s Disease

Everyone has been there. You are about to get into an accident, your heart races, your mind is completely focused on the oncoming car, time seems to slow, your thoughts become crystal clear. It's a near-death experience that you never forget. Your "stress response" has helped you to survive.Here's another scenario: your boss is shouting at you, your kids are sick, bills are piling up, life is getting really stressful on a chronic basis, day after day, and... after a while, you can't think straight! Your mind is racing, you have trouble paying attention and focusing, memory is impaired, worries abound, you can't make decisions or you make bad decisions, and depression may set in. Now the "stress response" is impairing your brain.What's going on here??Let's go back to basic biology. Long ago...

New Evidence Further Validates Ketone Body Therapy As An Effective Approach In Managing Alzheimer’s Disease

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer's disease (AD) patients. An early feature of AD is region specific declines in cerebral glucose metabolism...

New Evidence Further Validates Ketone Body Therapy As An Effective Approach In Managing Alzheimer’s Disease

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer's disease (AD) patients. An early feature of AD is region specific declines in cerebral glucose metabolism. One strategy has been to supplement the brain's normal glucose supply with ketone bodies. The company's data was drawn from two clinical studies which examined the cognitive effects of induced ketosis... (Source: Health News from Medical News Today)

New Evidence Further Validates Ketone Body Therapy As An Effective Approach In Managing Alzheimer’s Disease

Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced data which showed that augmentation with ketone bodies significantly improved cognitive function in Alzheimer's disease (AD) patients. An early feature of AD is region specific declines in cerebral glucose metabolism... (Source: Alzheimer's / Dementia News From Medical News Today)

Green tea nutrients may prevent glaucoma

We present these findings in protest of the way in which they were acquired.For more information: http://www.ncbi.nlm.nih.gov/pubmed/20085274 http://www.glaucoma.org/ http://www.nei.nih.gov/health/glaucoma/glaucoma_facts.asp (Source: NaturalNews.com)

Mitochondrial Dynamics in Alzheimers Disease: Opportunities for Future Treatment Strategies

(Source: Drugs)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Soluble βamyloid1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state?

Conclusions and implications: Our data suggest that soluble A[beta]-treated rats have a depressive, but not anxiogenic-like, profile, accompanied by brain region-dependent alterations in the expression of neurotrophins and 5-hydroxytryptaminergic neurotransmission. Hence, these alterations induced by soluble A[beta] might be sensitive indicators of early phases of AD and possible risk factors for the expression of neuropsychiatric symptoms in AD. (Source: British Journal of Pharmacology)

Older Entries